Parissenti AM, Pritzker LB, Dahle MA, Gythfeldt HVL, Masilamani T, Theriault G, St-Onge R, D'costa L, Lingjaerde OC, Haugen MH, Engebraaten O(2025) High mid-treatment tumour RNA disruption in patients with HER2-negative breast cancer is associated with improved disease-free survival after neoadjuvant chemotherapy Breast Cancer Res, 27(1), 143 DOI 10.1186/s13058-025-02092-9, PubMed 40790765
Carlsson PO, Hu X, Scholz H, Ingvast S, Lundgren T, Scholz T, Eriksson O, Liss P, Yu D, Deuse T, Korsgren O, Schrepfer S(2025) Survival of Transplanted Allogeneic Beta Cells with No Immunosuppression N Engl J Med(in press) DOI 10.1056/NEJMoa2503822, PubMed 40757665
Svestad JG, Mikalsen SG, Heydari M, Francke RH, Hervani M, Hellebust TP(2025) Setup Accuracy and Efficiency of Real-Time Video Assistance for Surface-Guided Positioning in Radiation Therapy of Right-Sided Locoregional Breast Cancer Adv Radiat Oncol, 10(9), 101829 DOI 10.1016/j.adro.2025.101829, PubMed 40757180